<DOC>
	<DOCNO>NCT00106288</DOCNO>
	<brief_summary>The purpose study determine efficacy safety micafungin ( FK463 ) versus liposomal amphotericin B ( AmBisome ) treat neutropenic non-neutropenic patient confirm invasive candidiasis candidemia . Enrollment include adult pediatric patient .</brief_summary>
	<brief_title>Micafungin Versus AmBisome Invasive Candidiasis Candidemia</brief_title>
	<detailed_description>A phase III , multicenter , double-blind , comparative , parallel , randomize study . Enrollment include adult pediatric patient . The adult population size test non-inferiority . For pediatric population , descriptive analysis plan .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidemia</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Micafungin</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Patients either nonneutropenic absolute neutrophil count &gt; = 500 cells/mm3 neutropenic absolute neutrophil count &lt; 500 cells/mm3 must : Candidemia invasive candidiasis , Confirmation typical clinical sign symptom fungal culture and/or histology , Positive culture obtain four day prior first dose study medication . Patient pregnant nursing Patients evidence liver disease define : ) SGOT/AST SGPT/ALT &gt; 10 time upper limit normal ( ULN ) ; b ) Total bilirubin &gt; 5 time ULN . Patients whose sole diagnosis oropharyngeal and/or esophageal candidiasis and/or positive culture urine specimen , sputum specimen , bronchoalveolarlavage specimen sample indwell drain . Patients receive prophylactic/empiric therapy azoles conventional amphotericin B three day within one week prior enrollment . Neutropenic patient , however , may receive prophylactic azoles without time restriction .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Candidaemia</keyword>
	<keyword>Micafungin</keyword>
</DOC>